Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Gastric dysplasia in the absence of an endoscopically defined lesion is rare, usually either a false positive diagnosis or a previously unidentified precancerous lesion during esophagogastroduodenoscopy (EGD).

Aims: Evaluate factors associated with the presence of an endoscopically visible lesion during follow-up in patients with histologic diagnosis of gastric dysplasia in random biopsies.

Methods: Retrospective cohort study including patients referred to our institution for gastric dysplasia in random biopsies during Index EGD. Endoscopic evaluation was performed with a high-definition endoscope using narrow band imaging (HD EGD-0). If no lesion was detected, endoscopic surveillance (HD EGD-FU) was conducted within 6 months for high grade dysplasia (HGD) or 12 months for low grade (LGD) or indefinite for dysplasia (IFD).

Results: From a total sample of 96 patients, 5 (5.2%) presented with an endoscopically visible lesion during HD EGD-0, while 10 lesions (10.4%) were identified during HD EGD-FU. Patients with infection at Index EDG and with regular alcohol consumption (≥25 g/day) were 8 and 4 times more likely to have an endoscopically visible lesion on HD EGD-FU ( = 0.012 and  = 0.047). In binary logistic regression, both factors were independent predictors of the presence of gastric lesion on HD EGD-FU (OR 9.284,  = 0.009 and OR 5.025,  = 0.033).

Conclusions: The presence of an endoscopically visible lesion after the histologic diagnosis of gastric dysplasia in random biopsies was more frequent during HD EGD-FU. infection at Index EGD and regular alcohol consumption were significant predictors of the presence of gastric lesion on HD EGD-FU.

Download full-text PDF

Source
http://dx.doi.org/10.1080/00365521.2023.2272563DOI Listing

Publication Analysis

Top Keywords

gastric dysplasia
20
dysplasia random
16
endoscopically visible
16
visible lesion
16
random biopsies
12
alcohol consumption
12
lesion egd-fu
12
lesion
10
presence endoscopically
8
histologic diagnosis
8

Similar Publications

A subset of gastric cancers (GCs) is linked to Epstein-Barr virus (EBV) infection. This study aims to characterize the histopathological and molecular features of EBV-associated GCs (EBVaGCs), focusing on predictive biomarkers and genomic and transcriptomic analysis. A total of 35 primary EBVaGCs were considered.

View Article and Find Full Text PDF

Importance: Children born very preterm have increased health care use. However, there is a lack of research using contemporary national data quantifying hospitalizations after neonatal discharge to inform counseling of families and health care provision.

Objective: To examine hospital admissions after neonatal discharge and before 2 years of age among children born at less than 32 weeks' gestation and assess associations between hospitalization and neonatal morbidities.

View Article and Find Full Text PDF

Background Gastric hyperplastic polyps (GHPs) represent a subset of gastric polyps that are clinically problematic when large and they can cause persistent, low-grade bleeding or gastric outlet obstruction. Rare malignant transformation has been reported, albeit not in our experience. Methods We retrospectively studied the clinicopathologic characteristics of large GHPs (≥20 mm) excised by endoscopic submucosal dissection (ESD) or endoscopic mucosal resection (EMR) between 2013 and 2020 at a single institution.

View Article and Find Full Text PDF

Gastric intestinal metaplasia (GIM) is considered a risk factor for gastric dysplasia and adenocarcinoma. While surveillance endoscopies are often performed, particularly for incomplete GIM, the clinical value of histologic subtyping (complete, incomplete, or mixed) remains unclear. This study evaluated the progression risk of different GIM subtypes diagnosed through random gastric biopsies and their association with various clinical factors.

View Article and Find Full Text PDF

The importance of infection in the development of non-alcoholic fatty liver disease, liver fibrosis, cirrhosis, insulin resistance, and non-alcoholic steatohepatitis has been shown in earlier studies. Our work aims to assess the risk of developing hepatic fibrosis in patients with or without , using noninvasive scores such as the APRI index, the BARD score, or the FIB-4 index, and to evaluate a possible association between the severity of fibrosis scores and histopathology evidence (such as chronic gastritis, gastric atrophy, gastric metaplasia, and gastric dysplasia). Moreover, the risk of preneoplastic stomach lesions was assessed in patients with hepatic fibrosis.

View Article and Find Full Text PDF